CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
President and CEO Richard Scott Struthers sold $822K of Crinetics Pharmaceuticals, Inc.
Sold$821,513
$37.37Price
21,981Shares
−2%Stake
What CRNX did after the filing
- The stock from Wed, Mar 18 close, $36.05
- +7.6%
- S&P 500, same days
- +8.7%
Measured over 30 trading days, to the Apr 30 close.
Traded Mon, Mar 16. Filed Wed, Mar 18, 1:05 PM ET, during the session. Returns use the Mar 18 close and the Apr 30 close. Not investment advice.